CLYM
CLYM
NASDAQ · Biotechnology

Climb Bio Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$12.08
+0.17 (+1.43%)
As of May 9, 1:52 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +116.1% upside
Low Target $17.52
Average Target $26.11
High Target $31.20
Current Price $12.08
Current
$12.08
Target
$26.11
$17.52 $26.11 avg $31.20
Scenario Analysis
Bear Case
$17.52
45.0%
Low target
Base Case
$26.11
+116.1%
Avg target
Bull Case
$31.20
+158.3%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$12.48
-3.2% from high
52-Week Low
$1.13
+969.0% from low
Target vs 52W High
$26.11
+109.2% vs high
Next Earnings Report
May 19, 2026
8d
until earnings
EPS Est: $-0.27
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%